|
|
Volumn 3, Issue 12, 2004, Pages 1198-1199
|
|
Two new agents effective in Gleevec-resistant CML
a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
DASATINIB;
ENZYME VARIANT;
IMATINIB;
NILOTINIB;
PROTEIN TYROSINE KINASE;
UNCLASSIFIED DRUG;
4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE;
4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANEMIA;
BLOOD CELL COUNT;
CANCER CENTER;
CANCER PATIENT;
CANCER RELAPSE;
CANCER SURVIVAL;
CELL DEATH;
CELL DIVISION;
CELL GROWTH;
CHROMOSOME 22;
CHROMOSOME 9;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
CRYSTALLOGRAPHY;
CYTOGENETICS;
DRUG ACTIVITY;
DRUG BINDING;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ENZYME STRUCTURE;
GENE MUTATION;
GROWTH REGULATION;
HEMATOPOIETIC STEM CELL;
HUMAN;
LEUKEMIA CELL;
LEUKOCYTE COUNT;
MAXIMUM TOLERATED DOSE;
NEUTROPENIA;
NOTE;
ONCOGENE;
PHILADELPHIA 1 CHROMOSOME;
SCREENING;
THROMBOCYTOPENIA;
ARTICLE;
DRUG ANTAGONISM;
DRUG RESISTANCE;
PATHOLOGY;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
THIAZOLES;
|
|
EID: 22344444917
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: 10.4161/cbt.3.12.1393 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|